Press release article from our research archive:

The Research Works Updates Coverage of Provectus Pharmaceuticals.

Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT) (UIR: FRK2541) today announced that The Research Works, Inc., an equity research boutique, has updated coverage and its published report on the Company. The updated report is available online through Stocks on the Web, the web-publishing division of The Research Works, at http://www.stocksontheweb.com/pvct.pdf.

Citing Provectus' robust pipeline of prescription drug candidates and target markets for its OTC products that exceed $1 billion annually, analyst William J. Ritger noted, "It seems reasonable that there is substantial upside potential if the Company hits its operating milestones."

Since initiating ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!